Philip Went

6.4k total citations · 2 hit papers
86 papers, 4.7k citations indexed

About

Philip Went is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip Went has authored 86 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 36 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip Went's work include Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (8 papers). Philip Went is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (8 papers). Philip Went collaborates with scholars based in Switzerland, Italy and Austria. Philip Went's co-authors include Stephan Dirnhofer, Alexandar Tzankov, Stefano Pileri, Guido Sauter, Alessandro Lugli, Martina Mirlacher, Marcel Bundi, Patrick A. Baeuerle, Sandra Meier and S Dirnhofer and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Philip Went

83 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent EpCam protein expression in human carcinomas

2004 671 citations Philip Went, Alessandro Lugli et al. Human Pathology profile →
Nuclear signalling by tumour-associated antigen EpCAM

2009 565 citations Philip Went et al. profile →

Peers

Countries citing papers authored by Philip Went

Since Specialization

Citations

This map shows the geographic impact of Philip Went's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Went with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Went more than expected).

Fields of papers citing papers by Philip Went

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Went. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Went. The network helps show where Philip Went may publish in the future.

Co-authorship network of co-authors of Philip Went

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Went. A scholar is included among the top collaborators of Philip Went based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Went. Philip Went is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19 2021 ·Pathobiology ·Jasmin D. Haslbauer, Anna K. Stalder, (unknown), Stefano Bassetti, Kirsten D. Mertz, Philip Went, Matthias S. Matter, Alexandar Tzankov	4
2	Profound and durable responses with PD-1 immune checkpoint inhibitors in patients with metastatic penile squamous cell carcinoma 2020 ·SHILAP Revista de lepidopterología ·(unknown), Philip Went, Richard Cathomas, Dirk Kienle	3
3	Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias 2014 ·Journal of Hepatology ·Xiaoye Schneider‐Yin, (unknown), (unknown), Philip Went, Jasmin Barman‐Aksözen, Reno S. Bladergroen, Paul Komminoth, Roy H. E. Cloots, Véronique Winnepenninckx, Axel zur Hausen, Markus Weber, Ann Driessen, Pamela Poblete‐Gutiérrez, Peter Bauer, Christopher Schroeder, Michel van Geel, Elisabeth I. Minder, Jorge Frank	19
4	Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors 2010 ·International Journal of Cancer ·Daniel Pérez, (unknown), Dirk Jäger, U Metzger, Eleftherios Pierre Samartzis, Philip Went, Achim A. Jungbluth	26
5	Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus 2010 ·European Journal of Surgical Oncology ·Urs Zingg, Maura Montani, Daniel M. Frey, Stefan Dirnhofer, Adrian Esterman, Philip Went, Daniel Oertli	50
6	Placental barrier in acute myeloid leukaemia 2008 ·British Journal of Haematology ·Michael D. Decker, Philip Went	3
7	Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets 2007 ·Journal of Clinical Investigation ·Pier Paolo Piccaluga, Claudio Agostinelli, Andrea Califano, Maura Rossi, Katia Basso, Simona Zupo, Philip Went, Ulf Klein, Pier Luigi Zinzani, Michele Baccarani, Riccardo Dalla Favera, Stefano Pileri	212
8	Diagnostic Problems in Follow-Up Bone Marrow Biopsies of Patients Treated for Acute and Chronic Leukaemias and MDS 2007 ·Pathobiology ·Stephan Dirnhofer, Philip Went, André Tichelli	4
9	Cancer‐associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling 2006 ·International Journal of Cancer ·Charles H. Lawrie, Teresa Marafioti, Christian S. R. Hatton, Stephan Dirnhofer, Giovanna Roncador, Philip Went, Alexandar Tzankov, Stefano Pileri, Karen Pulford, Alison H. Banham	34
10	Meningotheliomatöses Meningeom in einem reifen zystischen Teratom des Ovars 2006 ·Der Pathologe ·Heather Adams, Philip Went, Markus Tolnay, Gideon Sartorius, Gad Singer	3
11	2. Biology of Hodgkin's Disease 2005 ·Annals of Oncology ·(unknown), Kennosuke Karube, K Ohshima, Junji Suzumiya, Masahiro Kikuchi, Masafumi Harada, Alexandar Tzankov, (unknown), Annette Zimpfer, (unknown), Robert Maurer, Stefano Pileri, Philip Went, S Dirnhofer	1
12	Placental site trophoblastic tumor of the mediastinum 2005 ·Human Pathology ·Philip Went, Stephan Dirnhofer, (unknown), Christian Taverna, Gad Singer	7
13	Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis 2005 ·BMC Cancer ·Ellen C. Obermann, Philip Went, Annette Zimpfer, Alexandar Tzankov, Peter J. Wild, Robert Stoehr, Stefano Pileri, Stephan Dirnhofer	34
14	Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in Lymphomen: Eine Gewebe-Mikroarray-Studie an über 600 Non-Hodgkin-Lymphomen 2004 ·DMW - Deutsche Medizinische Wochenschrift ·Philip Went, (unknown), (unknown), Robert Maurer, Florian Augustin, Alexandar Tzankov, (unknown)	1
15	Aberrant expression of cell cycle regulators in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma 2004 ·Modern Pathology ·Alexandar Tzankov, Annette Zimpfer, Philip Went, Robert Maurer, Stefano Pileri, Stephan Geley, Stephan Dirnhofer	46
16	Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment 2004 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Alessandro Lugli, Philip Went, (unknown), Zariana Nikolova, Stefan Dirnhofer	11
17	Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in Lymphomen 2004 ·DMW - Deutsche Medizinische Wochenschrift ·Philip Went, (unknown), (unknown), Robert Maurer, Florian Augustin, Alexandar Tzankov, S Dirnhofer	12
18	Frequent EpCam protein expression in human carcinomas breakdown → 2004 ·Human Pathology ·Philip Went, Alessandro Lugli, Sandra Meier, Marcel Bundi, Martina Mirlacher, Guido Sauter, Stephan Dirnhofer	671
19	Morphologic Changes and Altered Gene Expression in an Epithelioid Hemangioendothelioma during a Ten-Year Course of Disease 2003 ·Pathology - Research and Practice ·Jean‐Philippe Theurillat, Stephan R. Vavricka, Philip Went, Dominik Weishaupt, Aurel Perren, (unknown), Esther Bächli	20
20	The presence of secretoneurin in human synovium and synovial fluid 1997 ·Neuroscience Letters ·Ursula Eder, Mika Hukkanen, Bernd Leitner, (unknown), Philip Went, Rudolf Kirchmair, Reiner Fischer‐Colbrie, J.M. Polak, Hans Winkler	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact